N/A
N=66
Study of the Long-term Effects of Exercise on Heath Indicators in Older People
Hypertension With Complications and Secondary Hypertension · Overweight and Obesity · Lipid Metabolism Disorders · Sarcopenia · Osteoporosis
Bottom Line
View on ClinicalTrials.gov: NCT01874132 ↗Enrolled (actual)
66
Serious AEs
4.6%
Results posted
Dec 2016
Primary outcome: Primary: Cardiovascular Disease Risk Factors — 3; 4; 5; 7 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Exercise training (Behavioral)
- Age
- Older Adult · 65+ yrs
- Sex
- Male
- Sponsor
- University of Trás-os-Montes and Alto Douro
- Primary completion
- Sep 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cardiovascular Disease Risk Factors |
3; 4; 5; 7; 5; 8 | — |
| SECONDARY Risk of Falls |
7; 6; 5; 15; 16; 17 | — |
Summary
Cardiovascular diseases (CVD) represent the most frequent cause of death among the elderly population. Hypertension, unfavorable lipid profile, obesity and physical inactivity are among the main risk factors for CVD. In contrast, mortality from CVD is inversely related to levels of physical activity, and is lower in individuals who exercise and have higher functional fitness levels. Thus, the Centers for Disease Control and Prevention, the American College of Sports Medicine, and the American Heart Association have recommended 20-30 min of moderate-to-vigorous aerobic training for the elderly, preferably every day or at least 3 days a week in the case of vigorous exercise.The same organizations also suggest the inclusion of resistance training in order to improve functional fitness. Therefore, the purpose of this study was to compare different exercise modalities in long-term changes of CVD risk factors and physical fitness among older adults.
Eligibility Criteria
Inclusion Criteria
- Older adults living independently;
- medical approval.
Exclusion Criteria
- Non-smokers;
- Non-morbidly obese;
- No history of severe hypertension;
- No history of falls;
- No orthopaedic, neurological, pulmonary, or cardiac problems.
Data sourced from ClinicalTrials.gov (NCT01874132). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.